In-house & bespoke training:
Industry

 

Please note: full product details will be shown on our training portal IPI Academy where you can find out more and book

Animal Health

Sample course outlines include:

  • A Practical Approach to Developing the CMC Package for Veterinary Pharmaceutical Products
  • A Practical Approach to Veterinary Vaccine Development and Registration in the EU

See all 10 course outlines

Biopharma

Sample course outlines include:

  • US FDA - Understanding Key Factors When Working with the FDA

See 1 course outline

Cosmetics

Sample course outlines include:

  • Cosmetovigilance

See 1 course outline

Medical Devices

Sample course outlines include:

  • A Regulatory Update on the Medical Device and In-Vitro Diagnostic Regulations in the EU and UK
  • Advanced Regulatory Affairs for Medical Devices

See all 52 course outlines

Pharmaceutical

Sample course outlines include:

  • A Practical Guide to Producing and Maintaining the PSMF
  • A Practical Guide to Writing Risk Management Plans (RMPs)

See all 97 course outlines

Training options

All of our course outlines are available:
Ready made for any number of participants or With a programme and presenters customised to your requirements
And in your preferred format, or combination:
Face-to-face training at your location or Webinar/interactive online

Previous attendees said...

“Content flow is well designed and good. [Parts I particularly liked were] process economy , Upstream and Downstream scale up.”

Arindam Gupta, Global Category Procurement Manager, Servier Monde

“Excellent, I am so please a colleague mentioned to IPI to me. ”

Julie Bailey, CFO, ILC Therapeutics Ltd

“another excellant [sic] webinar from IPI”

Toni Day, Global Director QARA, OrganOx Ltd

“Learned a lot! The presenter was definitely a subject matter expert who was able to answer my questions immediately. He didn't just read from the slides and was able to provide examples of concepts using real-life experience. I found the sections on the PSMF and Benefit vs. Risk particular helpful.”

Scott Aveni, Corp R&D QA, PV US Compliance Mgr., Chiesi USA

“As the person responsible of safety assessment and reporting in my department (clinical), I was hoping to strengthen my knowledge in this area. Especially when it comes to event assessment and classification.
This course helped me achieve that goal. [Speaker] is very knowledgeable on several topics.”

Stéphanie Trznadel, Clinical Trial Coordinator, SPINEART

“Excellent conference, speaker, material etc were perfectly balanced and understandable.”

Andrew Pearce, Corporate Quality & Regulatory Director, GVS

“The speaker demonstrated a deep understanding of pharmacovigilance and regulatory processes, providing valuable insights into the complexities of signal detection and risk management [with] real-world examples and case studies that were directly applicable to my work in drug safety and pharmacovigilance.”

Intan Soleha , Senior Executive, PHARMANIAGA BERHAD

“The speaker demonstrated a deep understanding of pharmacovigilance and regulatory processes, providing valuable insights into the complexities of signal detection and risk management.”

Intan Soleha , Senior Executive, PHARMANIAGA BERHAD

“I got useful information.”

Ravi Prabaharan, Research and Technology Manager, Advanced healthcare ltd

“He's a real guru and he's also a very good teacher.”

Juan Verde, MD, MSc, IHU Strasbourg